Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Guidelines for Long-Term Follow-Up after Childhood Cancer: Practical Implications for the Daily Work.

Gebauer J, Baust K, Bardi E, Grabow D, Stein A, van der Pal HJ, Calaminus G, Langer T.

Oncol Res Treat. 2020 Jan 13:1-7. doi: 10.1159/000504200. [Epub ahead of print] Review.

PMID:
31931503
2.

Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature review.

Salchow J, Mann J, Koch B, von Grundherr J, Jensen W, Elmers S, Straub LA, Vettorazzi E, Escherich G, Rutkowski S, Dwinger S, Bergelt C, Sokalska-Duhme M, Bielack S, Calaminus G, Baust K, Classen CF, Rössig C, Faber J, Faller H, Hilgendorf I, Gebauer J, Langer T, Metzler M, Schuster S, Niemeyer C, Puzik A, Reinhardt D, Dirksen U, Sander A, Köhler M, Habermann JK, Bokemeyer C, Stein A.

BMC Cancer. 2020 Jan 6;20(1):16. doi: 10.1186/s12885-019-6492-5.

3.

Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years.

Limond J, Thomas S, Bull KS, Calaminus G, Lemiere J, Traunwieser T, van Santen HM, Weiler L, Spoudeas HA, Chevignard M.

Eur J Paediatr Neurol. 2019 Oct 25. pii: S1090-3798(19)30391-5. doi: 10.1016/j.ejpn.2019.10.002. [Epub ahead of print]

PMID:
31753708
4.

Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours.

Hayden J, Murray MJ, Bartels U, Ajithkumar T, Muthusamy B, Penn A, Calaminus G, Nicholson J.

Arch Dis Child. 2019 Oct 8. pii: archdischild-2019-317245. doi: 10.1136/archdischild-2019-317245. [Epub ahead of print]

PMID:
31594777
5.

Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy.

Calaminus G, Jenney M, Hjorth L, Baust K, Bernstein M, Bielack S, Vos P, Hogendoorn PCW, Jovic G, Krailo M, Kreitz K, Marina N, Popoola BO, Sauerland C, Smeland S, Teske C, Schweinitz CV, Whelan J, Wiener A, Sydes MR, Nagarajan R.

JMIR Res Protoc. 2019 Sep 26;8(8):e14406. doi: 10.2196/14406.

6.

The Postopera tive Quality of Life in Children and Adolescents with Craniopharyngioma.

Eveslage M, Calaminus G, Warmuth-Metz M, Kortmann RD, Pohl F, Timmermann B, Schuhmann MU, Flitsch J, Faldum A, Müller HL.

Dtsch Arztebl Int. 2019 May 3;116(18):321-328. doi: 10.3238/arztebl.2019.0321.

7.

The European Society of Paediatric Oncology Ependymoma-II program Core-Plus model: Development and initial implementation of a cognitive test protocol for an international brain tumour trial.

Thomas S, Reynolds D, Morrall MCHJ, Limond J, Chevignard M, Calaminus G, Poggi G, Bennett E, Frappaz D, Slade D, Gautier J, McQuilton P, Massimino M, Grundy R.

Eur J Paediatr Neurol. 2019 Jul;23(4):560-570. doi: 10.1016/j.ejpn.2019.05.009. Epub 2019 May 18.

PMID:
31182404
8.

[Current research on pediatric and adult germ cell tumors : A report from the first "Düsseldorfer Testis Cancer Day"].

Nettersheim D, Oing C, Schönberger S, Skowron M, Vermeulen M, Müller M, Watolla M, Bremmer F, Pfister D, Calaminus G, Looijenga L, Lorch A, Albers P.

Urologe A. 2019 Jul;58(7):804-808. doi: 10.1007/s00120-019-0954-x. German. No abstract available.

PMID:
31119354
9.

Chromosomal gains of 12p and 1q are not associated with inferior outcome of pediatric and adolescent germ cell tumors.

Greimelmaier K, Calaminus G, Kristiansen G, Vokuhl C, Klapper W.

Pediatr Blood Cancer. 2019 Aug;66(8):e27777. doi: 10.1002/pbc.27777. Epub 2019 May 2.

PMID:
31045322
10.

Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma.

Bogusz A, Boekhoff S, Warmuth-Metz M, Calaminus G, Eveslage M, Müller HL.

Endocr Connect. 2019 May 1;8(5):481-492. doi: 10.1530/EC-19-0074.

11.

Health status, Health-Related Quality of Life and Socio-economic Outcome in Childhood Brain Tumor Survivors: a German Cohort Study.

Scholtes C, Baust K, Weinhold L, Creutzig U, Gnekow A, Hinz A, Kaatsch P, Kreitz K, Langer T, Rutkowski S, Singer S, Spix C, Teske C, Schmid M, Dilloo D, Calaminus G.

Neuro Oncol. 2019 Feb 22. pii: noz044. doi: 10.1093/neuonc/noz044. [Epub ahead of print]

PMID:
30793186
12.

Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort.

Smeland S, Bielack SS, Whelan J, Bernstein M, Hogendoorn P, Krailo MD, Gorlick R, Janeway KA, Ingleby FC, Anninga J, Antal I, Arndt C, Brown KLB, Butterfass-Bahloul T, Calaminus G, Capra M, Dhooge C, Eriksson M, Flanagan AM, Friedel G, Gebhardt MC, Gelderblom H, Goldsby R, Grier HE, Grimer R, Hawkins DS, Hecker-Nolting S, Sundby Hall K, Isakoff MS, Jovic G, Kühne T, Kager L, von Kalle T, Kabickova E, Lang S, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Mayer-Steinacker R, Meyers PA, Nagarajan R, Randall RL, Reichardt P, Renard M, Rechnitzer C, Schwartz CL, Strauss S, Teot L, Timmermann B, Sydes MR, Marina N.

Eur J Cancer. 2019 Mar;109:36-50. doi: 10.1016/j.ejca.2018.11.027. Epub 2019 Jan 25.

13.
14.

PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents.

Byrne J, Grabow D, Campbell H, O'Brien K, Bielack S, Am Zehnhoff-Dinnesen A, Calaminus G, Kremer L, Langer T, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Baust K, Bautz A, Beck JD, Berger C, Binder H, Borgmann-Staudt A, Broer L, Cario H, Casagranda L, Clemens E, Deuster D, de Vries A, Dirksen U, Winther JF, Fosså S, Font-Gonzalez A, Grandage V, Haupt R, Hecker-Nolting S, Hjorth L, Kaiser M, Kenborg L, Kepak T, Kepáková K, Knudsen LE, Krawczuk-Rybak M, Kruseova J, Kuehni CE, Kunstreich M, Kuonen R, Lackner H, Leiper A, Loeffen EAH, Luks A, Modan-Moses D, Mulder R, Parfitt R, Paul NW, Ranft A, Ruud E, Schilling R, Spix C, Stefanowicz J, Strauβ G, Uitterlinden AG, van den Berg M, van der Kooi AL, van Dijk M, van Leeuwen F, Zolk O, Zöller D, Kaatsch P; PanCareLIFE consortium.

Eur J Cancer. 2018 Nov;103:227-237. doi: 10.1016/j.ejca.2018.08.007. Epub 2018 Sep 29.

PMID:
30273888
15.

Genetic variation in gonadal impairment in female survivors of childhood cancer: a PanCareLIFE study protocol.

van der Kooi ALF, Clemens E, Broer L, Zolk O, Byrne J, Campbell H, van den Berg M, Berger C, Calaminus G, Dirksen U, Winther JF, Fosså SD, Grabow D, Haupt R, Kaiser M, Kepak T, Kremer L, Kruseova J, Modan-Moses D, Ranft A, Spix C, Kaatsch P, Laven JSE, van Dulmen-den Broeder E, Uitterlinden AG, van den Heuvel-Eibrink MM; PanCareLIFE Consortium.

BMC Cancer. 2018 Sep 26;18(1):930. doi: 10.1186/s12885-018-4834-3.

16.

Fertility Among Female Survivors of Childhood, Adolescent, and Young Adult Cancer: Protocol for Two Pan-European Studies (PanCareLIFE).

van den Berg M, van Dijk M, Byrne J, Campbell H, Berger C, Borgmann-Staudt A, Calaminus G, Dirksen U, Winther JF, Fossa SD, Grabow D, Grandage VL, van den Heuvel-Eibrink MM, Kaiser M, Kepak T, Kremer LC, Kruseova J, Kuehni CE, Lambalk CB, van Leeuwen FE, Leiper A, Modan-Moses D, Morsellino V, Spix C, Kaatsch P, van Dulmen-den Broeder E; PanCareLIFE Consortium.

JMIR Res Protoc. 2018 Sep 14;7(9):e10824. doi: 10.2196/10824.

17.

Long-term survivors of childhood cancer: cure and care-the Erice Statement (2006) revised after 10 years (2016).

Jankovic M, Haupt R, Spinetta JJ, Beck JD, Byrne J, Calaminus G, Lackner H, Biondi A, Oeffinger K, Hudson M, Skinner R, Reaman G, van der Pal H, Kremer L, den Hartogh J, Michel G, Frey E, Bardi E, Hawkins M, Rizvi K, Terenziani M, Valsecchi MG, Bode G, Jenney M, de Vathaire F, Garwicz S, Levitt GA, Grabow D, Kuehni CE, Schrappe M, Hjorth L; participants in PanCare.

J Cancer Surviv. 2018 Oct;12(5):647-650. doi: 10.1007/s11764-018-0701-0. Epub 2018 Jun 26.

PMID:
29946794
18.

DNA methylation-based classification of central nervous system tumours.

Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blümcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schüller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM.

Nature. 2018 Mar 22;555(7697):469-474. doi: 10.1038/nature26000. Epub 2018 Mar 14.

19.

Type, Frequency, and Spatial Distribution of Immune Cell Infiltrates in CNS Germinomas: Evidence for Inflammatory and Immunosuppressive Mechanisms.

Zapka P, Dörner E, Dreschmann V, Sakamato N, Kristiansen G, Calaminus G, Vokuhl C, Leuschner I, Pietsch T.

J Neuropathol Exp Neurol. 2018 Feb 1;77(2):119-127. doi: 10.1093/jnen/nlx106.

PMID:
29237087
20.

Quality of life and growth after childhood craniopharyngioma: results of the multinational trial KRANIOPHARYNGEOM 2007.

Heinks K, Boekhoff S, Hoffmann A, Warmuth-Metz M, Eveslage M, Peng J, Calaminus G, Müller HL.

Endocrine. 2018 Feb;59(2):364-372. doi: 10.1007/s12020-017-1489-9. Epub 2017 Dec 11.

PMID:
29230635
21.

Late Effects and Long-Term Follow-Up after Cancer in Childhood.

Langer T, Grabow D, Steinmann D, Wörmann B, Calaminus G.

Oncol Res Treat. 2017;40(12):746-750. doi: 10.1159/000484936. Epub 2017 Nov 29. Review.

PMID:
29183026
22.

Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.

Calaminus G, Frappaz D, Kortmann RD, Krefeld B, Saran F, Pietsch T, Vasiljevic A, Garre ML, Ricardi U, Mann JR, Göbel U, Alapetite C, Murray MJ, Nicholson JC.

Neuro Oncol. 2017 Nov 29;19(12):1661-1672. doi: 10.1093/neuonc/nox122.

23.

Brentuximab vedotin exerts profound antiproliferative and pro-apoptotic efficacy in CD30-positive as well as cocultured CD30-negative germ cell tumour cell lines.

Schönberger S, van Beekum C, Götz B, Nettersheim D, Schorle H, Schneider DT, Casati A, Craveiro RB, Calaminus G, Dilloo D.

J Cell Mol Med. 2018 Jan;22(1):568-575. doi: 10.1111/jcmm.13344. Epub 2017 Sep 22.

24.

Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial.

Câmara-Costa H, Bull KS, Kennedy C, Wiener A, Calaminus G, Resch A, Kieffer V, Lalande C, Poggi G, von Hoff K, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M; Quality of Survival working group of the Brain Tumour Group of SIOP-Europe.

Neurooncol Pract. 2017 Sep;4(3):161-170. doi: 10.1093/nop/npw028. Epub 2017 Feb 10.

25.

Health-related quality of life in paediatric patients with congenital heart defects: association with the type of heart defect and the surgical technique.

Heusch A, Kahl HJ, Hensel KO, Calaminus G.

Qual Life Res. 2017 Nov;26(11):3111-3117. doi: 10.1007/s11136-017-1653-y. Epub 2017 Jul 20.

PMID:
28730300
26.

Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.

Murray MJ, Bailey S, Heinemann K, Mann J, Göbel UK, Saran F, Hale JP, Calaminus G, Nicholson JC.

Int J Cancer. 2017 Aug 1;141(3):621-635. doi: 10.1002/ijc.30755. Epub 2017 May 15.

27.

Clinical and Radiologic Outcomes in Adults and Children Treated with Pencil-Beam Scanning Proton Therapy for Low-Grade Glioma.

Badiyan SN, Ulmer S, Ahlhelm FJ, Fredh ASM, Kliebsch U, Calaminus G, Bolsi A, Albertini F, Leiser D, Timmermann B, Malyapa RS, Schneider R, Lomax AJ, Weber DC.

Int J Part Ther. 2017 Spring;3(4):450-460. doi: 10.14338/IJPT-16-00031.1. Epub 2017 Jul 11. Erratum in: Int J Part Ther. 2017 Spring;3(4):i.

28.

Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.

Ripperger T, Bielack SS, Borkhardt A, Brecht IB, Burkhardt B, Calaminus G, Debatin KM, Deubzer H, Dirksen U, Eckert C, Eggert A, Erlacher M, Fleischhack G, Frühwald MC, Gnekow A, Goehring G, Graf N, Hanenberg H, Hauer J, Hero B, Hettmer S, von Hoff K, Horstmann M, Hoyer J, Illig T, Kaatsch P, Kappler R, Kerl K, Klingebiel T, Kontny U, Kordes U, Körholz D, Koscielniak E, Kramm CM, Kuhlen M, Kulozik AE, Lamottke B, Leuschner I, Lohmann DR, Meinhardt A, Metzler M, Meyer LH, Moser O, Nathrath M, Niemeyer CM, Nustede R, Pajtler KW, Paret C, Rasche M, Reinhardt D, Rieß O, Russo A, Rutkowski S, Schlegelberger B, Schneider D, Schneppenheim R, Schrappe M, Schroeder C, von Schweinitz D, Simon T, Sparber-Sauer M, Spix C, Stanulla M, Steinemann D, Strahm B, Temming P, Thomay K, von Bueren AO, Vorwerk P, Witt O, Wlodarski M, Wössmann W, Zenker M, Zimmermann S, Pfister SM, Kratz CP.

Am J Med Genet A. 2017 Apr;173(4):1017-1037. doi: 10.1002/ajmg.a.38142. Epub 2017 Feb 7. Review.

PMID:
28168833
29.

Nachsorge von krebskranken Kindern, Jugendlichen und jungen Erwachsenen-Erkennen, Vermeiden und Behandeln von Spatfolgen.

Schuster S, Beck JD, Calaminus G, Zehnhoff-Dinnesen AA, Langer T.

Kinderkrankenschwester. 2017 Jan;36(1):20-29. Review. English, German. No abstract available.

PMID:
30388336
30.

Germ Cell Tumors in Adolescents and Young Adults.

Calaminus G, Joffe J.

Prog Tumor Res. 2016;43:115-27. doi: 10.1159/000447081. Epub 2016 Sep 5. Review.

PMID:
27595361
31.

Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.

Marina NM, Smeland S, Bielack SS, Bernstein M, Jovic G, Krailo MD, Hook JM, Arndt C, van den Berg H, Brennan B, Brichard B, Brown KLB, Butterfass-Bahloul T, Calaminus G, Daldrup-Link HE, Eriksson M, Gebhardt MC, Gelderblom H, Gerss J, Goldsby R, Goorin A, Gorlick R, Grier HE, Hale JP, Hall KS, Hardes J, Hawkins DS, Helmke K, Hogendoorn PCW, Isakoff MS, Janeway KA, Jürgens H, Kager L, Kühne T, Lau CC, Leavey PJ, Lessnick SL, Mascarenhas L, Meyers PA, Mottl H, Nathrath M, Papai Z, Randall RL, Reichardt P, Renard M, Safwat AA, Schwartz CL, Stevens MCG, Strauss SJ, Teot L, Werner M, Sydes MR, Whelan JS.

Lancet Oncol. 2016 Oct;17(10):1396-1408. doi: 10.1016/S1470-2045(16)30214-5. Epub 2016 Aug 25.

32.

CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways.

Schulte SL, Waha A, Steiger B, Denkhaus D, Dörner E, Calaminus G, Leuschner I, Pietsch T.

Oncotarget. 2016 Aug 23;7(34):55026-55042. doi: 10.18632/oncotarget.10392.

33.

Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy.

Leiser D, Calaminus G, Malyapa R, Bojaxhiu B, Albertini F, Kliebsch U, Mikroutsikos L, Morach P, Bolsi A, Walser M, Timmermann B, Lomax T, Schneider R, Weber DC.

Radiother Oncol. 2016 Jul;120(1):163-8. doi: 10.1016/j.radonc.2016.05.013. Epub 2016 May 28.

PMID:
27247053
34.

Strategies to improve the quality of survival for childhood brain tumour survivors.

Tallen G, Resch A, Calaminus G, Wiener A, Leiss U, Pletschko T, Friedrich C, Langer T, Grabow D, Driever PH, Kortmann RD, Timmermann B, Pietsch T, Warmuth-Metz M, Bison B, Thomale UW, Krauss J, Mynarek M, von Hoff K, Ottensmeier H, Frühwald M, Kramm CM, Temming P, Müller HL, Witt O, Kordes U, Fleischhack G, Gnekow A, Rutkowski S; German Paediatric Brain Tumour Consortium (HIT-Network).

Eur J Paediatr Neurol. 2015 Nov;19(6):619-39. doi: 10.1016/j.ejpn.2015.07.011. Epub 2015 Jul 26. Review.

PMID:
26278499
35.

Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.

Câmara-Costa H, Resch A, Kieffer V, Lalande C, Poggi G, Kennedy C, Bull K, Calaminus G, Grill J, Doz F, Rutkowski S, Massimino M, Kortmann RD, Lannering B, Dellatolas G, Chevignard M; Quality of Survival Working Group of the Brain Tumour Group of SIOP-Europe.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):978-985. doi: 10.1016/j.ijrobp.2015.04.023. Epub 2015 Apr 17.

PMID:
26194675
36.

Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

Bielack SS, Smeland S, Whelan JS, Marina N, Jovic G, Hook JM, Krailo MD, Gebhardt M, Pápai Z, Meyer J, Nadel H, Randall RL, Deffenbaugh C, Nagarajan R, Brennan B, Letson GD, Teot LA, Goorin A, Baumhoer D, Kager L, Werner M, Lau CC, Sundby Hall K, Gelderblom H, Meyers P, Gorlick R, Windhager R, Helmke K, Eriksson M, Hoogerbrugge PM, Schomberg P, Tunn PU, Kühne T, Jürgens H, van den Berg H, Böhling T, Picton S, Renard M, Reichardt P, Gerss J, Butterfass-Bahloul T, Morris C, Hogendoorn PC, Seddon B, Calaminus G, Michelagnoli M, Dhooge C, Sydes MR, Bernstein M; EURAMOS-1 investigators.

J Clin Oncol. 2015 Jul 10;33(20):2279-87. doi: 10.1200/JCO.2014.60.0734. Epub 2015 Jun 1. Erratum in: J Clin Oncol. 2016 Nov 20;34(33):4059.

37.

Development of curative therapies for Ewing sarcomas by interdisciplinary cooperative groups in Europe.

Bölling T, Braun-Munzinger G, Burdach S, Calaminus G, Craft A, Delattre O, Deley MC, Dirksen U, Dockhorn-Dworniczak B, Dunst J, Engel S, Faldum A, Fröhlich B, Gadner H, Göbel U, Gosheger G, Hardes J, Hawkins DS, Hjorth L, Hoffmann C, Kovar H, Kruseova J, Ladenstein R, Leuschner I, Lewis IJ, Oberlin O, Paulussen M, Potratz J, Ranft A, Rössig C, Rübe C, Sauer R, Schober O, Schuck A, Timmermann B, Tirode F, van den Berg H, van Valen F, Vieth V, Willich N, Winkelmann W, Whelan J, Womer RB.

Klin Padiatr. 2015 May;227(3):108-15. doi: 10.1055/s-0035-1545263. Epub 2015 May 18.

PMID:
25985445
38.

Quality of survival assessment in European childhood brain tumour trials, for children aged 5 years and over.

Limond JA, Bull KS, Calaminus G, Kennedy CR, Spoudeas HA, Chevignard MP; Brain Tumour Quality of Survival Group, International Society of Paediatric Oncology (Europe) (SIOP-E).

Eur J Paediatr Neurol. 2015 Mar;19(2):202-10. doi: 10.1016/j.ejpn.2014.12.003. Epub 2014 Dec 17.

PMID:
25617909
39.

Ovarian Sertoli Leydig cell tumours in children and adolescents: an analysis of the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT).

Schneider DT, Orbach D, Cecchetto G, Stachowicz-Stencel T, Brummel B, Brecht IB, Bisogno G, Ferrari A, Reguerre Y, Godzinski J, Bien E, Calaminus G, Göbel U, Patte C.

Eur J Cancer. 2015 Mar;51(4):543-50. doi: 10.1016/j.ejca.2014.11.013. Epub 2014 Dec 13.

PMID:
25514863
40.

Pediatric germ cell tumors from 1987 to 2011: incidence rates, time trends, and survival.

Kaatsch P, Häfner C, Calaminus G, Blettner M, Tulla M.

Pediatrics. 2015 Jan;135(1):e136-43. doi: 10.1542/peds.2014-1989. Epub 2014 Dec 8.

PMID:
25489016
41.

Testicular germ cell tumors in adolescents - results of the protocol MAHO 98 and the identification of good risk patients.

Göbel U, Calaminus G, Haas R, Teske C, Schönberger S, Schneider DT, Leuschner I, Harms D.

Klin Padiatr. 2014 Nov;226(6-7):316-22. doi: 10.1055/s-0034-1387748. Epub 2014 Nov 28.

PMID:
25431864
42.

EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

Whelan JS, Bielack SS, Marina N, Smeland S, Jovic G, Hook JM, Krailo M, Anninga J, Butterfass-Bahloul T, Böhling T, Calaminus G, Capra M, Deffenbaugh C, Dhooge C, Eriksson M, Flanagan AM, Gelderblom H, Goorin A, Gorlick R, Gosheger G, Grimer RJ, Hall KS, Helmke K, Hogendoorn PC, Jundt G, Kager L, Kuehne T, Lau CC, Letson GD, Meyer J, Meyers PA, Morris C, Mottl H, Nadel H, Nagarajan R, Randall RL, Schomberg P, Schwarz R, Teot LA, Sydes MR, Bernstein M; EURAMOS collaborators.

Ann Oncol. 2015 Feb;26(2):407-14. doi: 10.1093/annonc/mdu526. Epub 2014 Nov 24.

43.

Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy.

Weber DC, Ares C, Malyapa R, Albertini F, Calaminus G, Kliebsch U, Mikroutsikos L, Morach P, Bolsi A, Lomax T, Schneider R.

J Neurooncol. 2015 Jan;121(2):389-97. doi: 10.1007/s11060-014-1648-2. Epub 2014 Nov 2.

PMID:
25362544
44.

Health related quality of life after corrective surgery for congenital heart disease.

Heusch A, Calaminus G, Kahl J, Schmidt K.

Klin Padiatr. 2014 Sep;226(5):281-6. doi: 10.1055/s-0034-1382019. Epub 2014 Jul 25.

PMID:
25062110
45.

Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007.

Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, Calaminus G, Müller HL.

Klin Padiatr. 2014 May;226(3):161-8. doi: 10.1055/s-0034-1368785. Epub 2014 May 12.

PMID:
24819386
46.

S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013.

Wagner U, Harter P, Hilpert F, Mahner S, Reuß A, du Bois A, Petru E, Meier W, Ortner P, König K, Lindel K, Grab D, Piso P, Ortmann O, Runnebaum I, Pfisterer J, Lüftner D, Frickhofen N, Grünwald F, Maier BO, Diebold J, Hauptmann S, Kommoss F, Emons G, Radeleff B, Gebhardt M, Arnold N, Calaminus G, Weisse I, Weis J, Sehouli J, Fink D, Burges A, Hasenburg A, Eggert C.

Geburtshilfe Frauenheilkd. 2013 Sep;73(9):874-889. No abstract available.

47.

Heart rate variability reflects the natural history of physiological development in healthy children and is not associated with quality of life.

Seifert G, Calaminus G, Wiener A, Cysarz D.

PLoS One. 2014 Mar 13;9(3):e91036. doi: 10.1371/journal.pone.0091036. eCollection 2014.

48.

Neuropsychological outcome in patients with childhood craniopharyngioma and hypothalamic involvement.

Özyurt J, Thiel CM, Lorenzen A, Gebhardt U, Calaminus G, Warmuth-Metz M, Müller HL.

J Pediatr. 2014 Apr;164(4):876-881.e4. doi: 10.1016/j.jpeds.2013.12.010. Epub 2014 Feb 6.

PMID:
24507865
49.

Quality of life in long-term survivors following treatment for Hodgkin's disease during childhood and adolescence in the German multicentre studies between 1978 and 2002.

Calaminus G, Dörffel W, Baust K, Teske C, Riepenhausen M, Brämswig J, Flechtner HH, Singer S, Hinz A, Schellong G.

Support Care Cancer. 2014 Jun;22(6):1519-29. doi: 10.1007/s00520-013-2114-y. Epub 2014 Jan 12.

PMID:
24415000
50.

Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma.

Kennedy C, Bull K, Chevignard M, Culliford D, Dörr HG, Doz F, Kortmann RD, Lannering B, Massimino M, Navajas Gutiérrez A, Rutkowski S, Spoudeas HA, Calaminus G; PNET4 study group of the Brain Tumour Group of The European branch of the International Society of Paediatric Oncology (SIOP-E).

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):292-300. doi: 10.1016/j.ijrobp.2013.09.046. Epub 2013 Nov 13.

PMID:
24239386

Supplemental Content

Loading ...
Support Center